These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19671806)

  • 21. Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis.
    Spadaro A; Riccieri V
    Ann Rheum Dis; 2005 Aug; 64(8):1241-2. PubMed ID: 16014691
    [No Abstract]   [Full Text] [Related]  

  • 22. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis.
    Tamai M; Kawakami A; Uetani M; Takao S; Tanaka F; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Kamachi M; Huang M; Origuchi T; Ida H; Aoyagi K; Eguchi K
    Ann Rheum Dis; 2006 Jan; 65(1):133-4. PubMed ID: 16344500
    [No Abstract]   [Full Text] [Related]  

  • 23. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis].
    Lequerré T; Richez C
    Rev Prat; 2012 Oct; 62(8):1088-9. PubMed ID: 23227605
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.
    Matsui T; Shimada K; Tohma S
    Clin Rheumatol; 2006 Jul; 25(4):610-1. PubMed ID: 16283420
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
    Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
    Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care.
    Pincus T; Sokka T
    J Rheumatol; 2009 Jun; 36(6):1099-100. PubMed ID: 19509086
    [No Abstract]   [Full Text] [Related]  

  • 30. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Syed RH; Gilliam BE; Moore TL
    Ann Rheum Dis; 2008 Jul; 67(7):1049-51. PubMed ID: 18556446
    [No Abstract]   [Full Text] [Related]  

  • 32. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
    Shmerling RH
    Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 34. [The vicious circle that leads to rheumatoid arthritis; experimental evidence of the steps involved in this circle].
    van Venrooij WJ; Pruijn GJ
    Ned Tijdschr Geneeskd; 2009; 153():B232. PubMed ID: 19785789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-citrullinated peptide/protein antibodies and structural prognosis of rheumatoid arthritis: quantity versus quality.
    Meyer O
    J Rheumatol; 2012 Apr; 39(4):675-6. PubMed ID: 22467946
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical interest of autoantibodies directed against citrullinated peptides in Indian patients with rheumatoid arthritis.
    Goëb V
    Indian J Med Sci; 2009 Mar; 63(3):89-91. PubMed ID: 19359775
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis.
    Kim DA; Jearn LH; Kim TY
    J Rheumatol; 2007 Sep; 34(9):1944-5. PubMed ID: 17787055
    [No Abstract]   [Full Text] [Related]  

  • 38. Citrullinated antigens: just diagnostic tools or pathogenic targets in rheumatoid arthritis?
    Feist E; Burmester GR
    J Rheumatol; 2006 Nov; 33(11):2103-4. PubMed ID: 17086596
    [No Abstract]   [Full Text] [Related]  

  • 39. "KISS"--embracing routine patient assessment.
    Uhlig T
    J Rheumatol; 2009 Jun; 36(6):1096-8. PubMed ID: 19509085
    [No Abstract]   [Full Text] [Related]  

  • 40. Reactivity of IgG antibody with cyclic citrullinated peptide occurs through the F(ab)'2 part of the Ig molecule.
    Burlingame RW
    J Rheumatol; 2005 May; 32(5):964-5. PubMed ID: 15909375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.